dc.creator | Morais, Clarice Neuenschwander Lins de | |
dc.creator | Carvalho, Bruno de Melo | |
dc.creator | Melo, Wlademir Gomes de | |
dc.creator | Melo, Fábio Lopes de | |
dc.creator | Lopes, Edmundo Pessoa de Almeida | |
dc.creator | Domingues, Ana Lúcia Coutinho | |
dc.creator | Jucá, Norma | |
dc.creator | Martins, João Roberto Maciel | |
dc.creator | Diniz, George Tadeu Nunes | |
dc.creator | Montenegro, Silvia Maria Lucena | |
dc.date | 2018-04-26T12:03:44Z | |
dc.date | 2018-04-26T12:03:44Z | |
dc.date | 2010 | |
dc.date.accessioned | 2023-09-26T22:44:46Z | |
dc.date.available | 2023-09-26T22:44:46Z | |
dc.identifier | MORAIS, C. N. L. DE et al. Correlation of biological serum markers with the degree of hepatic fibrosis and necroinflammatory activity in hepatitis C and schistosomiasis patients. Memorias Do Instituto Oswaldo Cruz, v. 105, n. 4, p. 460–466, jul. 2010. | |
dc.identifier | 1678-8060 | |
dc.identifier | https://www.arca.fiocruz.br/handle/icict/26119 | |
dc.identifier | 10.1590/S0074-02762010000400018 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8882673 | |
dc.description | PAPES V/FIOCRUZ, CNPq (to SMLM) | |
dc.description | Liver biopsy is the gold-standard method to stage fibrosis; however, it is an invasive procedure and is potentially dangerous. The main objective of this study was to evaluate biological markers, such as cytokines IL-13, IFN-gamma, TNF-alpha and TGF-beta, platelets, bilirubins (Bil), alanine aminotransferase (ALT) and aspartate aminotransferase (AST), total proteins, gamma-glutamil transferase (gamma-GT) and alkaline phosphatase (AP), that could be used to predict the severity of hepatic fibrosis in schistosomiasis and hepatitis C (HC) as isolated diseases or co-infections. The following patient groups were selected: HC (n = 39), HC/hepatosplenic schistosomiasis (HSS) (n = 19), HSS (n = 22) and a control group (n = 13). ANOVA and ROC curves were used for statistical analysis. P < 0.05 was considered significant. With HC patients we showed that TNF-alpha (p = 0.020) and AP (p = 0.005) could differentiate mild and severe fibrosis. With regard to necroinflammatory activity, AST (p = 0.002), gamma-GT (p = 0.034) and AP (p = 0.001) were the best markers to differentiate mild and severe activity. In HC + HSS patients, total Bil (p = 0.008) was capable of differentiating between mild and severe fibrosis. In conclusion, our study was able to suggest biological markers that are non-invasive candidates to evaluate fibrosis and necroinflammatory activity in HC and HC + HSS. | |
dc.format | application/pdf | |
dc.language | eng | |
dc.rights | open access | |
dc.subject | Marcadores biológicos | |
dc.subject | Fibrose hepática | |
dc.subject | HC | |
dc.subject | Esquistossomose | |
dc.subject | Biological markers | |
dc.subject | Hepatic fibrosis | |
dc.subject | HC | |
dc.subject | Schistosomiasis | |
dc.subject | Adolescente | |
dc.subject | Adulto | |
dc.subject | Análise de variação | |
dc.subject | Idoso | |
dc.subject | Biomarcadores / sangue | |
dc.subject | Estudos de caso-controle | |
dc.subject | Hepatite C / sangue | |
dc.subject | Hepatite C / complicações | |
dc.subject | Hepatite C / patologia | |
dc.subject | Humanos | |
dc.subject | Cirrose Hepática / sangue | |
dc.subject | Cirrose Hepática / complicações | |
dc.subject | Cirrose hepática / patologia | |
dc.subject | Hepatopatias Parasitárias / sangue | |
dc.subject | Hepatopatias Parasitárias / complicações | |
dc.subject | Hepatopatias Parasitárias / patologia | |
dc.subject | Meia idade | |
dc.subject | Necrose / patologia | |
dc.subject | Curva ROC | |
dc.subject | Esquistossomose / sangue | |
dc.subject | Esquistossomose / complicações | |
dc.subject | Esquistossomose / patologia | |
dc.subject | Índice de Gravidade da Doença | |
dc.subject | Doenças esplênicas / sangue | |
dc.subject | Doenças esplênicas / complicações | |
dc.subject | Doenças esplênicas / patologia | |
dc.subject | Adulto jovem | |
dc.title | Correlation of biological serum markers with the degree of hepatic fibrosis and necroinflammatory activity in hepatitis C and schistosomiasis patients | |
dc.type | Article | |